# Does Dual Therapy Hasten Antidepressant Response?

> **NCT00519428** · PHASE4 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 245 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** escitalopram
- **DRUG:** bupropion extra long (XL)
- **DRUG:** escitalopram + bupropion

## Key facts

- **NCT ID:** NCT00519428
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2011-07
- **Final completion:** 2012-03
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2017-10-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519428, "Does Dual Therapy Hasten Antidepressant Response?". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00519428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*